نتایج جستجو برای: monotherapy

تعداد نتایج: 15178  

2016
Yeon Hee Park Chae Uk Chung Bo Mi Park Myoung Rin Park Dong Il Park Jae Young Moon Hee Sun Park Jin Hwan Kim Sung Soo Jung Ju Ock Kim Sun Young Kim Jeong Eun Lee

Purpose. Topotecan and belotecan are camptothecin derivatives that are used to treat small cell lung cancer (SCLC). This study compared the toxicities and efficacies of belotecan and topotecan monotherapies in patients with SCLC. Methods. We retrospectively reviewed data from 94 patients with SCLC (with or without prior chemotherapy) who were treated using belotecan monotherapy (n = 59, 188 cyc...

2016
Nikita Shekhar Sawantdesai Pravin Popatrao Kale Jay Savai

CONTEXT Anxiety disorders are chronic, common, and often comorbid. There is an unmet need in its treatment. Aripiprazole and hydroxyzine are well-known therapeutic options used as monotherapy in clinics. They have different mechanisms and site of actions. AIM The objective of the present study was to evaluate the anxiolytic effect of aripiprazole and hydroxyzine in combination. MATERIALS AN...

Journal: :Preventive cardiology 2004
David M Capuzzi John M Morgan Christina M Carey Charles Intenzo Thomas Tulenko Dana Kearney Kalen Walker Michael D Cressman

Combination therapy with a statin and niacin may provide optimal therapy for patients with combined hyperlipidemia and low levels of high-density lipoprotein (HDL) cholesterol. The authors assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic dyslipidemia. In a 24-week, ...

2013
Yasuo Yoshioka Ken Yoshida Hideya Yamazaki Norio Nonomura Kazuhiko Ogawa

High-dose-rate (HDR) brachytherapy as monotherapy is a comparatively new brachytherapy procedure for prostate cancer. In addition to the intrinsic advantages of brachytherapy, including radiation dose concentration to the tumor and rapid dose fall-off at the surrounding normal tissue, HDR brachytherapy can yield a more homogeneous and conformal dose distribution through image-based decisions fo...

2017
Ondrej Viklicky Petra Hruba Stefan Tomiuk Sabrina Schmitz Bernhard Gerstmayer Birgit Sawitzki Patrick Miqueu Petra Mrazova Irena Tycova Eva Svobodova Eva Honsova Uwe Janssen Hans-Dieter Volk Petra Reinke

BACKGROUND There is high medical need for safe long-term immunosuppression monotherapy in kidney transplantation. Selective targeting of post-transplant alloantigen-(re)activated effector-T cells by anti-TNF antibodies after global T cell depletion may allow safe drug minimization, however, it is unsolved what might be the best maintenance monotherapy. METHODS In this open, prospective observ...

Journal: :Annals of the rheumatic diseases 2009
D van der Heijde G Burmester J Melo-Gomes C Codreanu E Martin Mola R Pedersen D Robertson D Chang A Koenig B Freundlich

OBJECTIVE To determine the effect of changing from etanercept or methotrexate monotherapy to etanercept plus methotrexate combination therapy on radiographic progression in rheumatoid arthritis (RA) patients. METHODS Patients enrolled in this 1-year open-label study previously completed a 3-year blinded study in which they received methotrexate or etanercept monotherapy or the combination of ...

2016
Francesca Ferretti Alba Bigoloni Laura Passeri Laura Galli Valeria Longo Simonetta Gerevini Vincenzo Spagnuolo Magnus Gisslen Henrik Zetterberg Dietmar Fuchs Dario Cattaneo Giada Caramatti Adriano Lazzarin Paola Cinque Antonella Castagna

BACKGROUND Cerebrospinal fluid (CSF) viral escape is a concern in ritonavir-boosted protease inhibitors monotherapy. The aim was to assess HIV-RNA, biomarkers of immune activation and neurodegeneration, and atazanavir concentrations in CSF of patients on successful long-term atazanavir/ritonavir (ATV/r) monotherapy. METHODS This is a substudy of the multicentric, randomized, open-label, nonin...

2015
Yan Song Yanni Hao Alexander R. Macalalad Peggy L. Lin James E. Signorovitch Eric Q. Wu

OBJECTIVE To describe patient profiles and clinical outcomes associated with first-line endocrine monotherapy (ET) and chemotherapy (CT) for postmenopausal HR+/HER2- metastatic breast cancer (mBC) patients. METHODS This is a retrospective chart review of 139 postmenopausal HR+/HER2- mBC patients initiating first-line ET monotherapy or CT. Overall survival (OS) was described using Kaplan-Meier...

Journal: :Gynecologic oncology 2007
Ashley S Case Rodney P Rocconi Edward E Partridge J Michael Straughn

OBJECTIVE The majority of patients with advanced epithelial ovarian cancer (EOC) will experience a recurrence after primary chemotherapy and receive second-line chemotherapy. Patients who have a disease-free interval >6 months (platinum-sensitive) will often receive multiple chemotherapy regimens. Therefore, our goal was to assess the effectiveness and medical costs of chemotherapy for platinum...

Journal: :Hormones 2005
Valentin V Fadeyev Tatiana B Morgunova Julia P Sytch Galina A Melnichenko

The aim of this study was to evaluate parameters of thyroid function in patients with primary hypothyroidism receiving either monotherapy with L-T4 or combination L-T4+L-T3. Fifty-eight women with primary hypothyroidism receiving L-T4 were enrolled in the study. The patients were randomised into two groups: Group 1 (n=42) patients continued monotherapy with L-T4, and Group 2 (n=16) patients wer...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید